Chacko Maryanne S, Adamo Martin L
Department of Biochemistry, University of Texas Health Science Center, San Antonio, Texas 78229-3900, USA.
Endocrinology. 2002 Feb;143(2):525-34. doi: 10.1210/endo.143.2.8628.
We previously demonstrated that Poly (IC) decreased the growth of C6 cultures in association with reduced IGF-I synthesis and secretion. In this study we characterized the mechanism(s) by which Poly (IC) decreased IGF-I mRNA in C6 cells. Both Poly (IC) and type I interferon (IFN) decreased IGF-I mRNA. Cycloheximide and a blocking antibody against IFN did not alter the Poly (IC)-mediated inhibition of IGF-I mRNA, but prevented IFN from reducing IGF-I mRNA. Poly (IC) did not alter the stability of IGF-I mRNA. Poly (IC) decreased the abundance of IGF-I pre-mRNA in C6 nuclei, but did not inhibit proximal IGF-I exon 1 promoter/luciferase fusion constructs in transient transfection assays. Poly (IC) activated double-stranded RNA-activated protein kinase (PKR) at 5 min and increased PKR protein levels at 48 and 72 h. Exogenous IGF-I did not prevent Poly (IC) from activating PKR, but inhibited the Poly (IC)-mediated increase in PKR protein levels. The PKR inhibitor 2-aminopurine prevented the Poly (IC) stimulation of eIF2-alpha phosphorylation and the Poly (IC)-mediated decrease in IGF-I mRNA. We conclude that Poly (IC) decreases IGF-I gene transcription in a mechanism that requires the activation of preexisting PKR, but not the induction of IFN or PKR proteins in C6 cells.
我们之前证明,聚肌胞苷酸(Poly (IC))可降低C6细胞培养物的生长,并伴有胰岛素样生长因子I(IGF-I)合成与分泌的减少。在本研究中,我们对Poly (IC)降低C6细胞中IGF-I mRNA的机制进行了表征。Poly (IC)和I型干扰素(IFN)均降低了IGF-I mRNA水平。环己酰亚胺和抗IFN阻断抗体并未改变Poly (IC)介导的对IGF-I mRNA的抑制作用,但可阻止IFN降低IGF-I mRNA。Poly (IC)并未改变IGF-I mRNA的稳定性。Poly (IC)降低了C6细胞核中IGF-I前体mRNA的丰度,但在瞬时转染实验中并未抑制IGF-I外显子1近端启动子/荧光素酶融合构建体。Poly (IC)在5分钟时激活双链RNA激活蛋白激酶(PKR),并在48小时和72小时时增加PKR蛋白水平。外源性IGF-I不能阻止Poly (IC)激活PKR,但可抑制Poly (IC)介导的PKR蛋白水平升高。PKR抑制剂2-氨基嘌呤可阻止Poly (IC)刺激真核翻译起始因子2α(eIF2-α)磷酸化以及Poly (IC)介导的IGF-I mRNA降低。我们得出结论,Poly (IC)通过一种需要激活预先存在的PKR,但不需要诱导C6细胞中IFN或PKR蛋白的机制来降低IGF-I基因转录。